US Broker Ratings

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 89.60% Revenue Growth and Strategic Partnerships

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has been making waves with its cutting-edge solutions in health information services. The company, headquartered in Chicago,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Potential Upside of 69% Amid Robust Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology industry, focusing on the development and commercialization of therapies for rare and life-threatening diseases. With a market..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Prospects

Guardant Health, Inc. (NASDAQ: GH) stands out in the healthcare sector as a leading player in the diagnostics and research industry, particularly in the realm of precision oncology. With a..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 41% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector’s medical instruments and supplies industry, is capturing investor attention with an enticing potential upside of 41%. With a robust..

Alcon Inc. (ALC) Stock Analysis: Exploring a 28.74% Potential Upside in Eye Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in eye care products, is drawing attention from investors with its promising 28.74% potential upside, according to analyst ratings. As a prominent player..

Sarepta Therapeutics (SRPT) Stock Analysis: A Biotech Player with a 68.40% Revenue Growth Surge

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, has captured considerable attention in the healthcare industry with its innovative approach to treating rare diseases. With a..

RadNet, Inc. (RDNT) Stock Analysis: Strong Buy Ratings Propel Investor Confidence Despite Valuation Challenges

RadNet, Inc. (NASDAQ: RDNT) is catching the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $5.86 billion, this Los..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and High ROE

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, operates within the medical distribution industry. With a market capitalization of $65.49 billion, it stands as a pivotal entity..

STERIS plc (STE) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

For investors seeking opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents an intriguing option. As a global leader in infection prevention solutions, STERIS operates with a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a Robust 12.99% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a formidable player in the biotechnology sector, has been capturing investor attention with its promising pipeline and solid market performance. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring an 18% Upside Potential

Investors keeping a close eye on the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) a compelling addition to their portfolios, given the company’s promising potential upside of..

Alkermes plc (ALKS) Stock Analysis: Uncovering a 43% Potential Upside in Healthcare Innovation

Alkermes plc (NASDAQ: ALKS), a leading player in the healthcare sector, presents a compelling investment opportunity with a potential upside of 43.32% according to recent analyst ratings. Specializing in the..

Ionis Pharmaceuticals (IONS) Stock Analysis: Navigating the 10.57% Upside Potential for Biotech Investors

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector with a market cap of $12.03 billion, showcasing its robust presence in the healthcare industry. Based in Carlsbad, California,..

West Pharmaceutical Services (WST) Stock Analysis: A 24.36% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $20.29 billion, West..

Inspire Medical Systems (INSP) Stock Analysis: Unveiling a Potential 62.87% Upside in the Medical Device Market

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneer in the healthcare sector, is making waves with its innovative solutions for obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, the..

ICON plc (ICLR) Investor Outlook: Exploring a 21% Upside with Strong Buy Ratings

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector specializing in diagnostics and research, is a name that might catch your eye, especially given its current market cap of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Riding a 17% Potential Upside Wave

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity. With a market cap of $6.03 billion, this San Francisco-based company is..

Haleon plc (HLN) Stock Analysis: Unpacking the 24.70% Upside Potential and Analyst Ratings

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the investment community with a compelling potential upside of 24.70%, according to current analyst ratings. This..

Elanco Animal Health (ELAN) Stock Analysis: A Look at Growth Potential in the Booming Animal Healthcare Sector

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a pivotal player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic animal products. With a..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 11.54% Potential Upside and Strong Market Presence Drive Investor Interest

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, particularly in Diagnostics & Research, stands out with a robust market capitalization of $50.36 billion. Headquartered in Westbrook,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds